Last month, Serena Williams opened up during an interview with TODAY, sharing that shes been taking a class of medication called GLP-1, often used for type 2 diabetes and obesity, to help with weight management
Waist circumference reductions were also dose-dependent for Cagrilintide, notably at 1.24.5 mg, exceeding those in the placebo group and approximating the reductions seen with liraglutide 3.0 mg
Not an approved product: GLP-1 agonists carry documented class cautions thyroid C-cell tumors seen in rodents (human relevance uncertain), pancreatitis signals, and gallbladder events [5] and the combination itself has not been reviewed or cleared by any regulator
The only exception is the use of alcohol in the crystallization step, which is a standard and controlled industrial practice
Phase 3 TRIUMPH trials use escalating subcutaneous doses: starting at 2mg weekly, titrating to 4mg, 8mg, and 12mg every 4 weeks